Research
Hormonal
Metformin provides modest weight loss (average ~2.1 kg/year) and improves insulin sensitivity, making it a first-line treatment for T2DM, though it is not FDA-approved specifically for weight loss.
Metformin is a standard first-line medication for Type 2 Diabetes. It helps control blood sugar and may lead to modest weight loss (about 2 kg per year), but it is not a powerful weight-loss drug. It is generally safe and well-tolerated, though some people experience gastrointestinal side effects.
StrongQualifiesHIGH confidence
According to the Diabetes Prevention Study (DPP), which is the largest study to show the weight benefits of metformin, the average weight reduction after one year on the medicine is only 2.1 kg [30].
Why this rating
Cites the large Diabetes Prevention Study (DPP).
Source
Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options
Angelica Artasensi et al. · Molecules · 2023
narrative_reviewCited 60×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →